Ancobon Capsule
Product Images NDC 0187-3555

3 FDA label images from Bausch Health Us Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ancobon (NDC 0187-3555). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bausch Health Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Ancobon 01)

Chemical Structure (Ancobon 01)
Chemical structure of Flucytosine, showing a fluorinated pyrimidine ring with amine and carbonyl functional groups.*
FDA Label Image

Image 01

Image 01
Ancobon (flucytosine) 250 mg capsules packaging label shows a container with 100 capsules. The label includes the drug name, strength, dosage form, and note that each capsule contains 250 mg flucytosine. It is distributed by Bausch Health US LLC and includes storage instructions and child-resistant container information.*
FDA Label Image

Image 02

Image 02
The packaging label for Ancobon (flucytosine) capsules in 500 mg strength. The label shows a count of 100 capsules and is marked Rx only. It includes manufacturer and distributor information for Bausch Health US LLC and details on dosage and storage. The label emphasizes keeping the product out of reach of children and proper storage conditions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.